Remdesivir for COVID-19: Why Not Dose Higher?

被引：9
作者：
Yan, Victoria C. [1 ]
Mueller, Florian L. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2021年 / 65卷 / 04期
关键词：
COVID-19; GS-441524; drug metabolism; prodrug; remdesivir;
D O I：
10.1128/AAC.02713-20
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Critical reappraisal of remdesivir investigational trials in COVID-19
    Brouqui, P.
    Giraud-Gatineau, A.
    Raoult, D.
    NEW MICROBES AND NEW INFECTIONS, 2020, 38
  • [22] Use of remdesivir for COVID-19 in patients with hematologic cancer
    Alexandra Martin-Onraët
    Corazón Barrientos-Flores
    Diana Vilar-Compte
    Carolina Pérez-Jimenez
    Pamela Alatorre-Fernandez
    Clinical and Experimental Medicine, 2023, 23 : 2231 - 2238
  • [23] Why promoting a COVID-19 vaccine booster dose?
    Loubet, Paul
    Laureillard, Didier
    Martin, Aurelie
    Larcher, Romaric
    Sotto, Albert
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (06)
  • [24] Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir
    Monardo, Roberta
    Mastrangelo, Andrea
    Galli, Laura
    Tomelleri, Alessandro
    Spagnuolo, Vincenzo
    Oltolini, Chiara
    Ponta, Giacomo
    Campochiaro, Corrado
    Cavalli, Giulio
    Dagna, Lorenzo
    Ciceri, Fabio
    Cinque, Paola
    Scarpellini, Paolo
    Castagna, Antonella
    Ripa, Marco
    FUTURE VIROLOGY, 2024, 19 (01) : 11 - 17
  • [25] That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
    Davis, Matthew R.
    McCreary, Erin K.
    Pogue, Jason M.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 525 - 536
  • [26] A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
    Hashemian, Seyed MohammadReza
    Farhadi, Tayebeh
    Velayati, Ali Akbar
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3215 - 3222
  • [27] Severe COVID-19 Pneumonia in an Unvaccinated Female Treated With Remdesivir
    Ortega, Kaylee
    George, Andrew
    DeGeorge, Charlotte R.
    Stead, Thor S.
    Mangal, Rohan
    DeLosSantos, Jesse
    Ganti, Latha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [28] Liver and kidney function in patients with Covid-19 treated with remdesivir
    van Laar, Sylvia A.
    de Boer, Mark G. J.
    Gombert-Handoko, Kim B.
    Guchelaar, Henk-Jan
    Zwaveling, Juliette
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4450 - 4454
  • [29] Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy
    Jaroszewicz, Jerzy
    Kowalska, Justyna
    Pawlowska, Malgorzata
    Rogalska, Magdalena
    Zarebska-Michaluk, Dorota
    Rorat, Marta
    Lorenc, Beata
    Czupryna, Piotr
    Sikorska, Katarzyna
    Piekarska, Anna
    Dworzanska, Anna
    Zaleska, Izabela
    Mazur, Wlodzimierz
    Kozielewicz, Dorota
    Klos, Krzysztof
    Podlasin, Regina
    Angielski, Grzegorz
    Oczko-Grzesik, Barbara
    Figlerowicz, Magdalena
    Szetela, Bartosz
    Bolewska, Beata
    Franczak-Chmura, Paulina
    Flisiak, Robert
    Tomasiewicz, Krzysztof
    CANCERS, 2022, 14 (19)
  • [30] Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options
    Sreekanth Reddy, Obireddy
    Lai, Wing-Fu
    CHEMBIOCHEM, 2021, 22 (06) : 939 - 948
12345